March 6, 2026

Seqster unveils 1-Click DataLake for clinical trials

​Seqster has launched 1-Click DataLake, a real-world data platform to expedite trial design, recruitment as well as evidence generation for...

March 6, 2026

Liberate Bio gains licences for myeloid-specific CAR design patents

​Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to CAR designs tailored for myeloid cells, such...

March 5, 2026

Philips launches Rembra CT system for acute imaging

​Philips has unveiled its next-generation radiology CT system, Rembra, to address the challenges faced by acute and high-demand imaging settings.The...

March 5, 2026

HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours

​HUTCHMED has commenced a Phase I/IIa clinical trial of its second ATTC, HMPL-A580, targeting patients with unresectable, advanced or metastatic...

March 5, 2026

Affinia receives FDA fast track designation for AFTX-201

​Affinia Therapeutics has received the US FDA fast track designation for AFTX-201, a genetic medicine under investigation for treating BAG3-associated...

March 4, 2026

Droplet improves genomic analysis speed using NVIDIA Parabricks software

​Droplet Biosciences has reported a reduction in genomic analysis turnaround time for residual cancer detection by adopting GPU-accelerated workflows using...

March 4, 2026

Kyowa Kirin discontinues ongoing trials of rocatinlimab

​Kyowa Kirin has announced the global discontinuation of all ongoing clinical trials for rocatinlimab, an anti-OX40 monoclonal antibody under investigation...

March 4, 2026

Esperion to acquire Corstasis for cardiovascular franchise expansion

​Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a bumetanide nasal spray.The...

March 3, 2026

Roche’s Phase III trial of fenebrutinib in RMS meets primary endpoint

​Roche has reported that the pivotal Phase III FENhance 1 trial of its investigational BTK inhibitor, fenebrutinib, in RMS, achieved...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.